Revenue (Tables)

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

The following tables provide detail by sales category:


	2023						2022						2021
(in millions)	U.S.		Int’l		Total		U.S.		Int’l		Total		U.S.		Int’l		Total
Established Pharmaceutical Products —
Key Emerging Markets	$	—	$	3,807	$	3,807	$	—	$	3,766	$	3,766	$	—	$	3,565	$	3,565
Other	—		1,259		1,259		—		1,146		1,146		—		1,153		1,153
Total	—		5,066		5,066		—		4,912		4,912		—		4,718		4,718

Nutritionals —
Pediatric Nutritionals	1,977		1,957		3,934		1,562		1,919		3,481		2,192		2,106		4,298
Adult Nutritionals	1,436		2,784		4,220		1,357		2,621		3,978		1,364		2,632		3,996
Total	3,413		4,741		8,154		2,919		4,540		7,459		3,556		4,738		8,294

Diagnostics —
Core Laboratory	1,243		3,916		5,159		1,137		3,751		4,888		1,145		3,983		5,128
Molecular	172		402		574		370		625		995		566		861		1,427
Point of Care	396		169		565		372		153		525		384		152		536
Rapid Diagnostics	2,518		1,172		3,690		6,652		3,409		10,061		4,916		3,519		8,435
Total	4,329		5,659		9,988		8,531		7,938		16,469		7,011		8,515		15,526

Medical Devices —
Rhythm Management	1,085		1,170		2,255		1,029		1,090		2,119		1,018		1,180		2,198
Electrophysiology	1,008		1,187		2,195		909		1,018		1,927		778		1,129		1,907
Heart Failure	888		273		1,161		809		226		1,035		772		235		1,007
Vascular	978		1,703		2,681		864		1,619		2,483		915		1,739		2,654
Structural Heart	883		1,061		1,944		818		894		1,712		730		880		1,610
Neuromodulation	725		165		890		619		151		770		616		165		781
Diabetes Care	2,129		3,632		5,761		1,633		3,123		4,756		1,212		3,116		4,328
Total	7,696		9,191		16,887		6,681		8,121		14,802		6,041		8,444		14,485

Other	14		—		14		11		—		11		34		18		52

Total	$	15,452	$	24,657	$	40,109	$	18,142	$	25,511	$	43,653	$	16,642	$	26,433	$	43,075

Note: The Acelis Connected Health business was internally transferred from Rapid Diagnostics to Heart Failure on January 1, 2023. As a result, $115 million of sales in 2022 and $118 million of sales in 2021 were moved from Rapid Diagnostics to Heart Failure.

Schedule of Changes in Contract Liabilities

Changes in the contract liabilities during the period are as follows:


(in millions)
Contract Liabilities:
Balance at December 31, 2021	$	520
Unearned revenue from cash received during the period	578
Revenue recognized related to contract liability balance	(598)
Balance at December 31, 2022	500
Unearned revenue from cash received during the period	469
Revenue recognized related to contract liability balance	(424)
Balance at December 31, 2023	$	545